These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 8649615)
1. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood. Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615 [TBL] [Abstract][Full Text] [Related]
2. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood. Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556 [TBL] [Abstract][Full Text] [Related]
3. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients. Gu Y; Ding F; Qin H; Zhao H; Lin S Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226 [TBL] [Abstract][Full Text] [Related]
4. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Ureña P; Herbelin A; Zingraff J; Lair M; Man NK; Descamps-Latscha B; Drüeke T Nephrol Dial Transplant; 1992; 7(1):16-28. PubMed ID: 1316577 [TBL] [Abstract][Full Text] [Related]
5. Influence of dialysis membranes on interleukin-1 beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells. Higuchi T; Kuno T; Takahashi S; Kanmatsuse K Artif Organs; 1997 Apr; 21(4):265-71. PubMed ID: 9096797 [TBL] [Abstract][Full Text] [Related]
6. Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro. Tilg H; Shapiro L; Vannier E; Poutsiaka DD; Trehu E; Atkins MB; Dinarello CA; Mier JW J Immunol; 1994 Mar; 152(6):3189-98. PubMed ID: 8144913 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells. Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978 [TBL] [Abstract][Full Text] [Related]
9. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. Lonnemann G; Schindler R; Lufft V; Mahiout A; Shaldon S; Koch KM Nephrol Dial Transplant; 1995; 10(2):207-11. PubMed ID: 7753454 [TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Andersson J; Björk L; Dinarello CA; Towbin H; Andersson U Eur J Immunol; 1992 Oct; 22(10):2617-23. PubMed ID: 1396967 [TBL] [Abstract][Full Text] [Related]
11. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis. Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744 [TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. Re F; Mengozzi M; Muzio M; Dinarello CA; Mantovani A; Colotta F Eur J Immunol; 1993 Feb; 23(2):570-3. PubMed ID: 8436189 [TBL] [Abstract][Full Text] [Related]
13. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. Vogels MT; Mensink EJ; Ye K; Boerman OC; Verschueren CM; Dinarello CA; van der Meer JW J Immunol; 1994 Dec; 153(12):5772-80. PubMed ID: 7989774 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress. Pomianek MJ; Colton CK; Dinarello CA; Miller LC ASAIO J; 1996; 42(1):52-9. PubMed ID: 8808459 [TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. O'Nualláin EM; Puri P; Mealy K; Reen DJ Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873 [TBL] [Abstract][Full Text] [Related]
18. Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. Pue CA; Mortensen RF; Marsh CB; Pope HA; Wewers MD J Immunol; 1996 Feb; 156(4):1594-600. PubMed ID: 8568265 [TBL] [Abstract][Full Text] [Related]
19. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1. Lonnemann G; Koch KM; Shaldon S; Dinarello CA J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615 [TBL] [Abstract][Full Text] [Related]
20. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis. Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]